Scott Rottinghaus

Scott Rottinghaus

Chief Tech/Sci/R&D Officer at ENANTA PHARMACEUTICALS, INC.

Net worth: 317 081 $ as of 2026-08-30

53 year
Consumer Services
Health Technology

Profile

Scott T.
Rottinghaus
is currently Chief Medical Officer at Enanta Pharmaceuticals, Inc. since 2022.
Formerly, Dr. Rottinghaus was Vice President & Head-Clinical Development at Alexion Pharmaceuticals, Inc. and Assistant Clinical Professor at Yale School of Medicine from 2017 to 2019.
Education includes graduate studies at the University of Cambridge, undergraduate studies at Kansas State University, and a doctorate from Mayo Medical School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-08-07 23,787 ( 0.08% ) 317 081 $ 2026-08-30

Scott Rottinghaus active positions

CompaniesPositionStart
ENANTA PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2022-08-07

Former positions of Scott Rottinghaus

CompaniesPositionEnd
Corporate Officer/Principal 2018-12-31
ALEXION PHARMACEUTICALS, INC. Corporate Officer/Principal -
See the detail of Scott Rottinghaus's experience

Training of Scott Rottinghaus

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

35

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Consumer Services

  1. Stock Market
  2. Insiders
  3. Scott Rottinghaus
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!